🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

RecruitingPhase 2Ages 18 Years - anyAllDartmouth-Hitchcock Medical Center
NCT04678895 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Diabetes affects more than 30 million people in the United States and is a leading cause of morbidity. Over 25% diabetics also suffer from debilitating painful diabetic neuropathy in the lower legs and feet. This pain can be severe, difficult to control, and have a significant negative impact on quality of life. Opioid medications have historically been a mainstay of treatment for this pain, despite the risks. As the death toll from the U.S. opioid epidemic continues to rise, the need for quality alternative non-opioid medications to treat pain becomes more urgent. One of these potential medications is Low-Dose Naltrexone (LDN). This drug is reported to work by enhancing the body's natural pain relieving mechanisms and decreases inflammation by targeting specific cells called microglia which have been shown to influence chronic pain. LDN has been shown to be a safe medication with minima

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Diagnosis of Painful Diabetic Neuropathy (PDN) for \>6 months 2. Has failed at least one prior standard treatment for PDN (Gabapentin, duloxetine, etc) 3. No other known causes of lower extremity neuropathic pain 4. Subjects capable of giving informed consent 5. Greater than 18 years of age 6. Stable on all current non-opioid pain medication for at least 1 month 7. English as primary language Exclusion Criteria: 1. Known allergy to naltrexone or naloxone 2. Presence of known causes of lower extremity neuropathic pain not attributed to PDN 3. Active substance use disorder or alcohol use disorder as defined by DSM-V (The Diagnostic and Statistical Manual of Mental Disorders) 4. Current treatment for substance use disorder or alcohol use disorder 5. Current opioid therapy or on opioid therapy within the past 1 month
💊

What it tests

  • Naltrexone
  • Placebo
📍

Where

1 site
Dartmouth-Hitchcock Medical Center
Lebanon, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy